SARS-CoV-2–specific T cell activation with SARS-CoV-2 PepTivator® Peptide Pools скачать в хорошем качестве

SARS-CoV-2–specific T cell activation with SARS-CoV-2 PepTivator® Peptide Pools

Watch a short introduction into PepTivator® Peptide Pools and their application in SARS-CoV-2 research. Miltenyi Biotec’s peptide pools cover the amino acid sequence of distinct antigens. For SARS-CoV-2, research-grade products are available for the spike glycoprotein, nucleocapsid phosphoprotein, and membrane glycoprotein. The peptide pools can be used to load antigen-presentigen cells and to stimulate antigen-specific T cells. Activated SARS-CoV-2–specific T cells can subsequently be detected and/or isolated for further research. For more information, visit https://www.miltenyibiotec.com/lp/sar... PepTivator Peptide Pools consist of short 15-mer peptides with 11-amino-acid overlaps, covering the amino acid sequence of a particular virus-, tumor-, or auto-antigen. They bind to MHC class I as well as MHC class II complexes and thus are suitable for the antigen-specific stimulation of CD4+ and CD8+ T cells. Products containing 6 nmol per peptide are sufficient to stimulate up to 10⁸ cells and products containing 60 nmol per peptide are sufficient to stimulate up to 10⁹ cells. Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has 2,500 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.